These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8729733)

  • 1. Anticoagulant effects of antioxidant capacity.
    Rea CA; Maxwell SR; Maslin DJ; Thomason HL; Thorpe GH
    Ann Clin Biochem; 1996 Mar; 33 ( Pt 2)():174. PubMed ID: 8729733
    [No Abstract]   [Full Text] [Related]  

  • 2. Alcohol beverages and biochemical changes in blood.
    Gorinstein S; Trakhtenberg S
    Addict Biol; 2003 Dec; 8(4):445-54. PubMed ID: 14690881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anticoagulant choice on apparent total antioxidant capacity using three different methods.
    Goode HF; Richardson N; Myers DS; Howdle PD; Walker BE; Webster NR
    Ann Clin Biochem; 1995 Jul; 32 ( Pt 4)():413-6. PubMed ID: 7486802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total antioxidant power of plasma: male-female differences and effect of anticoagulant used.
    Benzie IF; Chung WY
    Ann Clin Biochem; 1999 Jan; 36 ( Pt 1)():104-6. PubMed ID: 10370770
    [No Abstract]   [Full Text] [Related]  

  • 5. Antioxidant and Anticoagulant Status Were Improved by Personalized Dietary Intervention Based on Biochemical and Clinical Parameters in Cancer Patients.
    Lee GY; Lee JJ; Lee SM
    Nutr Cancer; 2015; 67(7):1083-92. PubMed ID: 26333154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anticoagulant choice on apparent antioxidant capacity.
    Doherty G; Young IS
    Ann Clin Biochem; 1996 Jan; 33 ( Pt 1)():93-4. PubMed ID: 8929080
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of beta2-glycoprotein I, LDL-, and antioxidant levels in hypercholesterolemic elderly subjects.
    Gomes LF; Alves AF; Sevanian A; Peres Cde A; Cendoroglo MS; de Mello-Almada C; Quirino LM; Ramos LR; Junqueira VB
    Antioxid Redox Signal; 2004 Apr; 6(2):237-44. PubMed ID: 15025925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-polynitroxides: synthesis and preliminary evaluation as cardiovascular EPR/MR imaging probes and extracellular space-targeted antioxidants.
    Kleschyov AL; Sen' V; Golubev V; Münnemann K; Hinderberger D; Lackner KJ; Weber S; Terekhov M; Schreiber LM; Münzel T
    Eur J Med Chem; 2012 Dec; 58():265-71. PubMed ID: 23127990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation.
    Yamaji K; Wang Y; Liu Y; Abeyama K; Hashiguchi T; Uchimura T; Krishna Biswas K; Iwamoto H; Maruyama I
    Thromb Res; 2005; 115(4):319-25. PubMed ID: 15668192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunological effect of anticoagulant and antioxidant therapy in the prevention of abortion in mice.
    Junovich G; Dubinsky V; Gentile T; Sarto A; Pasqualini S; Gutiérrez G
    Am J Reprod Immunol; 2011 Feb; 65(2):104-9. PubMed ID: 20645940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problem of anticoagulant therapy in clinical neurology].
    HAUSMANOWA-PETRUSEWICZ I
    Neurol Neurochir Psychiatr Pol; 1960; 10():583-93. PubMed ID: 13712338
    [No Abstract]   [Full Text] [Related]  

  • 12. Popular naturally occurring antioxidants as potential anticoagulant drugs.
    Bijak M; Saluk J; Szelenberger R; Nowak P
    Chem Biol Interact; 2016 Sep; 257():35-45. PubMed ID: 27475864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory monitoring of anticoagulant and thrombolysis treatment].
    Vilpo J
    Duodecim; 1986; 102(9):551-9. PubMed ID: 3720592
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of plasmas from donors under oral anticoagulant treatment for the expression of INR values.
    Moritz B; Lang H
    Haematologica; 1997; 82(5):630-3. PubMed ID: 9407737
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characterization of a circulating anticoagulant found in a subject with lupus erythematosus. Preliminary note].
    Nenci GG; Notaristefano A
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1388-9. PubMed ID: 5397288
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory monitoring of oral anticoagulant therapy.
    Ginsberg JS; Hirsh J
    Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
    [No Abstract]   [Full Text] [Related]  

  • 17. [Circulating anticoagulant during anaphylactic shock in rabbit].
    BOUNAMEAUX Y; LECOMTE J
    C R Seances Soc Biol Fil; 1956; 150(12):2276-8. PubMed ID: 13437592
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of oral anticoagulant therapy with whole blood prothrombin time devices: the future has begun.
    Tripodi A
    Thromb Haemost; 2000 Sep; 84(3):362-3. PubMed ID: 11019955
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of plasma and whole-blood anticoagulant counter ion choice on drug stability and matrix effects during bioanalysis.
    Bergeron M; Bergeron A; Furtado M; Garofolo F
    Bioanalysis; 2009 Jun; 1(3):537-48. PubMed ID: 21083151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating anticoagulant in hemophilia A: laboratory evidence of a coagulation factor 8 inhibitor].
    Hule V
    Vnitr Lek; 1967 Sep; 13(9):859-65. PubMed ID: 6081657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.